J. Spoors

发表

Challenges in funding new developments in oncology

J. Spoors, 2013 .

Analysis of indirect treatment comparisons in national health technology assessment assessments and requirements for industry submissions.

J. Spoors, I. Es-Skali, 2018, Journal of comparative effectiveness research.

Recent trends in the pricing of high-cost pharmaceuticals

J. Kusel, J. Spoors, 2016 .

Discrete choice experiments: An overview of experience to date in haemophilia

A. Miners, J. Cairns, J. Spoors, 2022, The Journal of Haemophilia Practice.

Regeneration X: The payer perspective on gene therapy

A. Walker, J. Spoors, E. Croft, 2017 .

The funding of orphan medicines in the UK

J. Spoors, S. Bojakowski, 2014 .

The uptake of non-branded medicines: Fact, fiction and biosimilarities

J. Kusel, J. Spoors, 2015 .

Patient access schemes in the new NHS

John Spoors, J. Spoors, 2012 .

Early access schemes for innovative health technologies: the views of international stakeholders

G. Melendez‐Torres, M. Barnish, C. Farmer, 2023, International Journal of Technology Assessment in Health Care.

Payer and Implementation Challenges with Advanced Therapy Medicinal Products (ATMPs)

J. Cairns, A. Miners, J. Spoors, 2020, BioDrugs.